Pilot plant

Inhalation development and manufacturing for early and late-stage clinical supply.

Recipharm Inhalation Solutions™ offers comprehensive contract development and manufacturing solutions for early and late-phase clinical supply from our stand-alone pilot plant as part of our end-to-end inhalation offering.

Our pilot plant comprises seven independent suites totalling approximately 900m2 of manufacturing space to enable GMP supply of investigational medicinal products (IMPs), with a focus on nasal sprays and inhalers.

Learn more about our capabilities by downloading our fact sheet below.